Back
Sonoma Pharmaceuticals, Inc. 10K Form
Sell
29
SNOA
Sonoma Pharmaceuticals, Inc.
Last Price:
$3.53
Seasonality Move:
8.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SNOA News And Ratings
See the #1 stock for the next 7 days that we like better than SNOA
SNOA Financial Statistics
Sales & Book Value
| Annual Sales: | $14.3M |
|---|---|
| Cash Flow: | $-645K |
| Price / Cash Flow: | 23.61 |
| Annual Sales: | $2.30 |
| Price / Book: | 1.42 |
Profitability
| EPS (TTM): | -2.19380 |
|---|---|
| Net Income (TTM): | $-3.5M |
| Gross Margin: | $5.5M |
| Return on Equity: | -77.39% |
| Return on Assets: | -24.99% |
Sonoma Pharmaceuticals, Inc. Earnings Forecast
Key Sonoma Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 24 years for SNOA is 38.25%.
-
The Selling, General & Administrative Expenses for SNOA have been equal to 51.52% of Gross Profit Margin.
-
The Research & Development expenses have been 12.70% of Revenue.
-
The Net Earning history of SNOA is -24.20% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 14 years.
Sonoma Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SNOA |
| CUSIP: | 83558L |
| Website: | sonomapharma.com |
Debt
| Debt-to-Equity Ratio: | 0.14 |
|---|---|
| Current Ratio: | 2.85 |
| Quick Ratio: | 1.33 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SNOA Technical Analysis vs Fundamental Analysis
Sell
29
Sonoma Pharmaceuticals, Inc. (SNOA)
is a Sell
Is Sonoma Pharmaceuticals, Inc. a Buy or a Sell?
-
Sonoma Pharmaceuticals, Inc. stock is rated a SellThe current Sonoma Pharmaceuticals, Inc. [SNOA] share price is $3.57. The Score for SNOA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.